Dr. Michael Hoffman

Dr. Michael Hoffman, Chair of the Computational Biology and Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, and Associate Professor at the Department of Medical Biophysics, University of Toronto, will present his research on "Identifying transcription factor binding using open chromatin, transcriptome, and methylation data."

Meet the speaker

If you want to meet Dr. Michael Hoffman on Monday January 27th in Forskningsparken, please book a time slot using the jotform at https://form.jotform.com/250191396540355.

Abstract

First, we will discuss a new method, Virtual ChIP-seq which predicts binding of individual transcription factors in new cell types using an artificial neural network that integrates ChIP-seq results from other cell types and chromatin accessibility data in the new cell type. Virtual ChIP-seq also uses learned associations between gene expression and transcription factor binding at specific genomic regions. This approach outperforms methods that use transcription factor sequence preferences in the form of position weight matrices, predicting binding for 33 transcription factors.

Second, we will discuss a new method to discover transcription factor motifs and identify transcription factor binding sites in DNA with covalent modifications such as methylation. Just as transcription factors distinguish one standard nucleobase from another, they also distinguish unmodified and modified bases. To represent the modified bases in a sequence, we replace cytosine (C) with symbols for 5-methylcytosine (5mC), and 5-hydroxymethylcytosine (5hmC). Similarly, we adapted the well-established position weight matrix model of transcription factor binding affinity to an expanded alphabet. We created an expanded-alphabet genome sequence using genome-wide maps of 5mC, and 5hmC in mouse naive T cells. Using this sequence and expanded-alphabet position weight matrixes, we reproduced various known methylation binding preferences, including the preference of ZFP57 and C/EBPβ for methylated motifs and the preference of c-Myc for unmethylated motifs. Using these known binding preferences to tune model parameters enables discovery of novel modified motifs.

Published Jan. 20, 2025 9:12 AM - Last modified Jan. 20, 2025 9:22 AM